Analyst Activity – Credit Suisse Group Raises Its Price Target On Ascendis Pharma A/S (NASDAQ:ASND) to $78.00

Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)

Story continues below

Today, Credit Suisse Group raised its price target on Ascendis Pharma A/S (NASDAQ:ASND) to $78.00 per share.

Some recent analyst ratings include

  • 2/26/2018-Wedbush Reiterated Rating of Outperform.
  • 1/19/2018-HC Wainwright Reiterated Rating of Buy.
  • 1/17/2018-JPMorgan Chase & Co. Reiterated Rating of Buy.
  • 9/22/2017-Wells Fargo Reiterated Rating of Buy.
  • 9/1/2017-Leerink Swann Reiterated Rating of Hold.


    Recent Trading Activity for Ascendis Pharma A/S (NASDAQ:ASND)
    Shares of Ascendis Pharma A/S closed the previous trading session at 64.39 up +1.39 2.21% with 62.540000915527344 shares trading hands.

    An ad to help with our costs